Deciphering the Role of Glutamate Signaling in Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions

被引:15
|
作者
Mollazadeh, Hamid [1 ]
Mohtashami, Elmira [2 ]
Mousavi, Seyed H. [3 ]
Soukhtanloo, Mohammad [4 ]
Vahedi, Mohammad M. [5 ]
Hosseini, Azar [2 ]
Afshari, Amir R. [1 ]
Sahebkar, Amirhossein [6 ,7 ,8 ]
机构
[1] North Khorasan Univ Med Sci, Fac Med, Dept Physiol & Pharmacol, Bojnurd, Iran
[2] Mashhad Univ Med Sci, Pharmacol Res Ctr Med Plants, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Med Toxicol Res Ctr, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Fac Med, Dept Med Biochem, Mashhad, Razavi Khorasan, Iran
[5] Zahedan Univ Med Sci, Fac Med, Dept Pharmacol, Zahedan, Iran
[6] FDA, IRI, Halal Res Ctr, Tehran, Iran
[7] Mashhad Univ Med Sci, Biotechnol Res Ctr, Sch Med, Dept Med Biotechnol,Pharmaceut Technol Inst, POB 91779, Mashhad, Razavi Khorasan, Iran
[8] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran
关键词
Glioblastoma multiforme; glutamate; antagonist; invasion; apoptosis; current therapeutic modalities; C6; GLIOMA-CELLS; AMPA RECEPTORS; METABOTROPIC GLUTAMATE-RECEPTOR-1; INHIBITS PROLIFERATION; PHARMACOLOGICAL BLOCKADE; MALIGNANT GLIOMA; HIGH EXPRESSION; NMDA RECEPTORS; STEM-CELLS; GROUP-II;
D O I
10.2174/1381612826666200603132456
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As the most popular intrinsic neoplasm throughout the brain, glioblastoma multiforme (GBM) is resistant to existing therapies. Due to its invasive nature, GBM shows a poor prognosis despite aggressive surgery and chemoradiation. Therefore, identifying and understanding the critical molecules of GBM can help develop new therapeutic strategies. Glutamatergic signaling dysfunction has been well documented in neurodegenerative diseases as well as in GBM. Inhibition of glutamate receptor activation or extracellular glutamate release by specific antagonists inhibits cell development, invasion, and migration and contributes to apoptosis and autophagy in GBM cells. This review outlines the current knowledge of glutamate signaling involvement and current therapeutic modalities for the treatment of GBM.
引用
收藏
页码:4777 / 4788
页数:12
相关论文
共 50 条
  • [1] The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review
    Mohtashami, Elmira
    Shafaei-Bajestani, Negar
    Mollazadeh, Hamid
    Mousavi, Seyed Hadi
    Jalili-Nik, Mohammad
    Sahebkar, Amirhossein
    Afshari, Amir R.
    [J]. CURRENT DRUG METABOLISM, 2020, 21 (08) : 564 - 578
  • [2] Therapeutic advances for glioblastoma multiforme: Current status and future prospects
    Robins H.I.
    Chang S.
    Butowski N.
    Mehta M.
    [J]. Current Oncology Reports, 2007, 9 (1) : 66 - 70
  • [3] Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review
    Anjum, Komal
    Shagufta, Bibi Ibtesam
    Abbas, Syed Qamar
    Patel, Seema
    Khan, Ishrat
    Shah, Sayed Asmat Ali
    Akhter, Najeeb
    ul Hassan, Syed Shams
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2017, 92 : 681 - 689
  • [4] Current and Future Novel Treatments for Glioblastoma Multiforme
    Tyler, Betty
    DiMeco, Francesco
    Grossman, Rachel
    Pradilla, Gustavo
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [5] Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions
    Corso, Christopher D.
    Bindra, Ranjit S.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2016, 26 (04) : 281 - 298
  • [6] Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)
    Khabibov, Marsel
    Garifullin, Airat
    Boumber, Yanis
    Khaddour, Karam
    Fernandez, Manuel
    Khamitov, Firat
    Khalikova, Larisa
    Kuznetsova, Natalia
    Kit, Oleg
    Kharin, Leonid
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 60 (06)
  • [7] Potential therapeutic role of microRNAs in glioblastoma multiforme
    [J]. Nature Clinical Practice Neurology, 2008, 4 (10): : 526 - 526
  • [8] Deciphering the signaling pathways of cancer stem cells of glioblastoma multiforme: Role of Akt/mTOR and MAPK pathways
    Jhanwar-Uniyal, Meena
    Albert, Ladislau
    McKenna, Elise
    Karsy, Michael
    Rajdev, Priya
    Braun, Alex
    Murali, Raj
    [J]. ADVANCES IN ENZYME REGULATION, VOL 51, 2011, 51 : 164 - +
  • [9] The Role of γδ T-Lymphocytes in Glioblastoma: Current Trends and Future Directions
    Ahmedna, Taha
    Khela, Harmon
    Weber-Levine, Carly
    Azad, Tej D.
    Jackson, Christopher M.
    Gabrielson, Kathleen
    Bettegowda, Chetan
    Rincon-Torroella, Jordina
    [J]. CANCERS, 2023, 15 (24)
  • [10] Current Therapeutic Alternatives and New Perspectives in Glioblastoma Multiforme
    Arevalo, Angelo S. T.
    Erices, Jose I.
    Uribe, Daniel A.
    Howden, Jake
    Niechi, Ignacio
    Munoz, Sebastian
    Martin, Rody S.
    Monras, Claudia A. Q.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2017, 24 (25) : 2781 - 2795